PATENT CLAIM ANALYSIS

Application Number: 16014975
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-11
Patent Classification: ["514", "789000"]

Abstract:
The present invention discloses a new biomarker miR-134, miR-223, or IL-18, which is positively correlated with AOSD and activities thereof. By detecting the expression level of at least one biomarker in a sample, an effect of detecting the risk and prognosis of a sample provider suffering from a disease is achieved.

Claim (Index 2):
The method for treating AOSD according to  claim 1 , wherein the pharmaceutical composition is capable of reducing the expression of IL-18 in the individual.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14438715', '14989243', '13269404', '13005899', '14380672']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7117210879196262
- 35 USC 102 Novelty (BERT): 0.5310643678447572
- Combined Prediction Score: 0.6936554159121393
- Mean Citation Score: 232.09911
- Max Citation Score: 251.56865
- Similarity Product: 126.0575876842022

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test